A new rodent model of cerebral hyperperfusion

Area of Science:

• Neuroscience
• Cardiovascular Research
• Animal Modeling

Background:

• Limited fundamental research exists on post-carotid intervention hyperperfusion due to a lack of stable animal models.
• Existing studies primarily rely on clinical observations and meta-analyses in human patients.

Purpose of the Study:

• To develop and validate a rat model that reliably mimics the pathophysiological processes of hyperperfusion.
• To establish a preclinical tool for investigating hyperperfusion syndrome and related cerebrovascular conditions.

Main Methods:

• Global ischemia was induced via bilateral common carotid artery occlusion (BCAO) for two weeks, followed by reperfusion.
• Phenylephrine was administered at varying concentrations (10-120 μg/mL) to induce controlled hypertension.
• Cerebral blood flow and mean arterial pressure (MAP) were monitored using Laser Doppler techniques.

Main Results:

• Mild hypertension, achieved with phenylephrine around 30 μg/mL, significantly increased cerebral blood flow.
• Higher phenylephrine concentrations (≥80 μg/mL) led to cardiac dysfunction and arrhythmia, failing to induce hyperperfusion.
• The model demonstrated high phenotype reproducibility, low failure rates, and minimal animal mortality.

Conclusions:

• A phenylephrine dosage of 30-50 μg/mL effectively elevates MAP and cerebral blood flow over 100% of baseline in the rat model.
• This novel hyperperfusion model offers advantages for studying carotid stenosis and ischemia/reperfusion injury.
• The model provides a stable and reproducible platform for fundamental research into cerebrovascular events.